tiprankstipranks
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Financial Statements

468 Followers

Indaptus Therapeutics Financial Overview

Indaptus Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.78; its P/E ratio is -1.20; Indaptus Therapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ -110.00K
Gross Profit----$ -110.00K
EBIT$ -4.18M$ -3.92M$ -3.25M$ 4.53M$ -4.19M
EBITDA$ -4.18M$ -3.92M$ -3.24M$ 4.53M$ -4.19M
Net Income Common Stockholders$ -4.00M$ -3.92M$ -3.25M$ 4.53M$ -3.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.36M$ 15.96M$ 19.69M$ 21.68M$ 26.43M
Total Assets$ 14.92M$ 17.79M$ 20.84M$ 23.14M$ 28.06M
Total Debt$ 175.05K$ 196.24K$ 216.59K$ 236.51K$ 80.49K
Net Debt$ -13.19M$ -15.77M$ -19.48M$ -21.44M$ -26.35M
Total Liabilities$ 2.85M$ 2.46M$ 2.22M$ 1.96M$ 3.43M
Stockholders Equity$ 12.08M$ 15.33M$ 18.62M$ 21.23M$ 24.63M
Cash Flow-
Free Cash Flow$ -2.60M$ -3.73M$ -2.11M$ -4.96M$ -2.21M
Operating Cash Flow$ -2.60M$ -3.73M$ -2.11M$ -4.96M$ -2.21M
Investing Cash Flow-$ 7.00M$ 8.00M$ 2.14M$ 5.12M
Financing Cash Flow-----
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

Indaptus Therapeutics Debt to Assets

Indaptus Therapeutics Cash Flow

Indaptus Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis